비교리스트

 카트 문의
시장보고서
상품코드
1542785

세계의 크레아티닌 어세이 키트 시장

Creatinine Assay Kits
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 181 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

크레아티닌 어세이 키트 세계 시장 규모는 2030년까지 2억 2,720만 달러에 달할 것으로 전망

2023년 1억 9,500만 달러로 추정되는 크레아티닌 어세이 키트 세계 시장은 2030년에는 2억 2,720만 달러에 달할 것으로 예상되며, 분석 기간인 2023-2030년간 연평균 2.2% 성장할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 야호 키네틱 테스트 키트는 CAGR 2.1%를 기록하여 분석 기간이 끝날 때까지 1억 210만 달러에 도달할 것으로 예상됩니다. 크레아티닌-PAP 테스트 키트 분야의 성장률은 분석 기간 동안 CAGR 2.8%로 추정됩니다.

미국 시장 5,150만 달러로 추정, 중국은 CAGR 2.1%로 성장 전망

미국의 크레아티닌 어세이 키트 시장은 2023년 5,150만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 3,660만 달러 규모에 도달할 것으로 예상되며, 2023-2030년간의 분석 기간 동안 2.1%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.0%와 1.8%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 유럽에서는 독일이 연평균 2.4%의 성장률을 보일 것으로 예상됩니다.

세계 크레아티닌 어세이 키트 시장 - 주요 동향 및 촉진요인 정리

신장 검사 의료 진단에서 크레아티닌 어세이 키트가 중요한 이유는 무엇인가?

크레아티닌 어세이 키트는 혈액이나 소변 샘플의 크레아티닌 수치를 빠르고 정확하게 측정하는 임상 현장에서 필수적인 도구입니다. 크레아티닌은 근육 대사에서 발생하는 노폐물로 신장 기능의 중요한 지표입니다. 이 키트는 크레아티닌 농도를 평가하기 위해 야페의 속도론적 방법과 효소 분석을 포함한 다양한 방법을 활용합니다. 이 결과는 의료진이 신장 질환을 진단하고 모니터링하는 데 중요한 매개변수인 사구체여과율(GFR)을 평가하는 데 도움이 됩니다. 신장 기능이 저하되면 크레아티닌 농도가 상승하여 신장 손상이나 신부전 가능성을 시사합니다. 따라서 크레아티닌 측정은 신장 질환의 조기 발견과 지속적인 관리에 매우 중요한 역할을 하며, 적시에 개입하고 맞춤형 치료를 보장합니다.

크레아티닌 측정 기술의 발전은 어떻게 환자 치료를 향상시켰습니까?

크레아티닌 검사 분야에서는 이러한 검사의 정확성, 효율성 및 편의성을 향상시키는 중요한 기술 발전이 이루어졌습니다. 최신 크레아티닌 어세이 키트는 자동 분석기와 높은 호환성을 갖도록 설계되어 일상적인 실험실 워크플로우에 원활하게 통합될 수 있습니다. 이러한 발전에는 시료 내 다른 물질의 간섭을 줄이고 보다 신뢰할 수 있는 결과를 보장하는 개선된 시약 배합이 포함됩니다. 또한 POC(Point-of-Care) 크레아티닌 검사 장비의 개발은 즉각적인 임상적 판단을 지원하는 신속한 결과를 제공함으로써 특히 중환자 치료 및 응급 환자 관리에 혁명을 일으켰습니다. 이러한 기술 혁신은 환자 관리를 최적화할 뿐만 아니라 기존 검사 방법에 비해 검사 시간을 크게 단축시킵니다.

크레아티닌 어세이 키트의 사용에 영향을 미치는 문제는 무엇인가?

그러나 이러한 장점에도 불구하고 크레아티닌 어세이 키트의 보급은 몇 가지 문제에 직면해 있습니다. 가장 큰 문제 중 하나는 각 제조업체의 검사 설계와 민감도 차이로 인한 분석 결과의 편차가 있다는 것입니다. 이는 크레아티닌 측정값의 일관성 부족으로 이어져 신장 건강 관리에 대한 임상적 판단에 영향을 미칠 수 있습니다. 또한, 환자의 시료에 특정 화학물질이나 약물이 존재할 경우, 크레아티닌 측정의 정확성을 저해하여 크레아티닌 수치를 잘못 높게 또는 낮게 측정할 수 있습니다. 이러한 문제를 해결하기 위해서는 다양한 임상 환경과 집단에서 크레아티닌 측정의 신뢰성과 유효성을 보장하기 위한 지속적인 연구와 표준화 노력이 필요합니다.

크레아티닌 어세이 키트 시장을 촉진하는 주요 요인은?

크레아티닌 어세이 키트 시장의 성장은 예방적 건강 관리 및 만성 질환 관리에 대한 관심 증가를 반영하는 몇 가지 요인에 의해 주도되고 있습니다. 만성콩팥병(CKD)의 위험 요인으로 알려진 고혈압, 당뇨병과 같은 질환의 유병률이 증가함에 따라 일상적인 건강검진에서 크레아티닌 측정이 더 많이 사용되고 있습니다. 특히 신흥국의 의료 인프라 개발은 이러한 진단 검사에 대한 접근성을 확대하여 시장 성장을 더욱 촉진하고 있습니다. 또한, 신장 기능이 저하되기 쉬운 고령화 추세로 인해 정기적인 신장 기능 모니터링의 필요성이 강조되고 있습니다. 이러한 키트의 정확성과 사용 편의성을 향상시키는 기술 발전도 키트의 채택 확대에 기여하고 있습니다. 환자의 예후를 개선하고 의료비를 절감하기 위해 전 세계 의료 기관이 신장 질환의 조기 발견과 관리에 중점을 두고 있기 때문에 크레아티닌 어세이 키트 수요는 계속 증가할 것으로 예상됩니다.

조사 대상 기업 예시(총 46건)

  • Abbott Laboratories
  • Abcam PLC
  • Arbor Assays Inc.
  • BioAssay Systems
  • Biovision Inc.
  • Cayman Chemical Company
  • Cell Biolabs, Inc.
  • Crystal Chem, Inc.
  • Enzo Life Sciences, Inc.
  • Genway Biotech, Inc.
  • Merck KgaA
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • Tulip Diagnostics（P）Ltd.
  • Wako Pure Chemical Industries Ltd.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 24.09.04

Global Creatinine Assay Kits Market to Reach US$227.2 Million by 2030

The global market for Creatinine Assay Kits estimated at US$195.0 Million in the year 2023, is expected to reach US$227.2 Million by 2030, growing at a CAGR of 2.2% over the analysis period 2023-2030. Jaffe's Kinetic Test Kits, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$102.1 Million by the end of the analysis period. Growth in the Creatinine-PAP Test Kits segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$51.5 Million While China is Forecast to Grow at 2.1% CAGR

The Creatinine Assay Kits market in the U.S. is estimated at US$51.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$36.6 Million by the year 2030 trailing a CAGR of 2.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Creatinine Assay Kits Market - Key Trends and Drivers Summarized

Kidney Check: Why Are Creatinine Assay Kits Crucial in Medical Diagnostics?

Creatinine assay kits are essential tools in clinical settings, providing quick and accurate measurements of creatinine levels in blood and urine samples. Creatinine, a waste product generated from muscle metabolism, is a key indicator of kidney function. These kits utilize various methodologies, including Jaffe's kinetic method and enzymatic assays, to evaluate creatinine concentration. The results help healthcare providers assess the glomerular filtration rate (GFR), a critical parameter in diagnosing and monitoring kidney diseases. As kidney function declines, creatinine levels rise, signaling potential renal impairment or failure. Thus, creatinine assays play a pivotal role in early detection and ongoing management of kidney diseases, ensuring timely intervention and treatment customization.

How Have Advancements in Creatinine Assay Technology Enhanced Patient Care?

The field of creatinine testing has seen significant technological advancements that have enhanced the accuracy, efficiency, and convenience of these tests. Modern creatinine assay kits are designed for high compatibility with automated analyzers, allowing for seamless integration into routine laboratory workflows. These advancements include improved reagent formulations that reduce interference from other substances in the sample, ensuring more reliable results. Additionally, the development of point-of-care creatinine testing devices has revolutionized patient management, especially in critical care and emergency settings, by providing rapid results that support immediate clinical decisions. Such innovations not only optimize patient care but also significantly decrease the turnaround time compared to traditional laboratory methods.

What Challenges Influence the Use of Creatinine Assay Kits?

Despite their benefits, the deployment of creatinine assay kits faces several challenges. One major issue is the variability in assay results due to differences in test design and sensitivity among different manufacturers. This can lead to inconsistencies in creatinine measurements, affecting clinical decisions related to kidney health management. Furthermore, the presence of certain chemicals or drugs in patients' samples can interfere with the accuracy of creatinine assays, leading to either falsely elevated or reduced levels. Addressing these challenges requires ongoing research and standardization efforts to ensure that creatinine assays remain reliable and effective across diverse clinical environments and populations.

What Are the Major Drivers Propelling the Creatinine Assay Kits Market Forward?

The growth in the creatinine assay kits market is driven by several factors, reflecting an increased focus on preventive healthcare and chronic disease management. The rising prevalence of conditions such as hypertension and diabetes, which are known risk factors for chronic kidney disease (CKD), has led to greater use of creatinine assays in routine health screenings. Advances in healthcare infrastructure, particularly in developing countries, have expanded access to these diagnostic tests, further propelling market growth. Additionally, the aging global population, which is more susceptible to renal function decline, underscores the need for regular kidney function monitoring. Technological advancements that improve the accuracy and user-friendliness of these kits also contribute to their increased adoption. As health systems worldwide emphasize early detection and management of kidney disease to improve patient outcomes and reduce healthcare costs, the demand for creatinine assay kits is expected to continue rising.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Abcam PLC
  • Arbor Assays Inc.
  • BioAssay Systems
  • Biovision Inc.
  • Cayman Chemical Company
  • Cell Biolabs, Inc.
  • Crystal Chem, Inc.
  • Enzo Life Sciences, Inc.
  • Genway Biotech, Inc.
  • Merck KgaA
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • Tulip Diagnostics (P) Ltd.
  • Wako Pure Chemical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Creatinine Assay Kits - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Kidney Disease Propels Demand for Creatinine Assay Kits
    • Global Aging Population Drives Adoption of Kidney Function Tests
    • Growing Health Awareness and Preventative Care Boost Use of Creatinine Assays
    • Healthcare Infrastructure Expansion in Developing Countries Spurs Market Demand
    • Standardization of Renal Function Testing Protocols Bolsters Reliability and Adoption
    • Rise in Diabetes Incidence Intensifies Need for Routine Kidney Function Monitoring
    • Insurance Coverage for Routine Health Screening Supports Market Penetration
    • Impact of Telehealth on Remote Patient Monitoring Boosts Creatinine Assay Use
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Creatinine Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Creatinine Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Creatinine Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Creatinine-PAP Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Creatinine-PAP Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Creatinine-PAP Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for ELISA Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for ELISA Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for ELISA Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Creatinine Assay Kits Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Jaffe's Kinetic Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Jaffe's Kinetic Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Jaffe's Kinetic Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Blood / Serum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Blood / Serum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Blood / Serum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • JAPAN
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • CHINA
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • EUROPE
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Creatinine Assay Kits by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Creatinine Assay Kits by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Creatinine Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • FRANCE
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • GERMANY
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Creatinine Assay Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Creatinine Assay Kits by Type - Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Creatinine Assay Kits by Type - Percentage Breakdown of Value Sales for Jaffe's Kinetic Test Kits, Creatinine-PAP Test Kits and ELISA Test Kits for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Creatinine Assay Kits by Sample - Urine, Blood / Serum and Other Samples Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Creatinine Assay Kits by Sample - Percentage Breakdown of Value Sales for Urine, Blood / Serum and Other Samples for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제